期刊文献+

2014—2017年复旦大学附属妇产科医院碳青霉烯类抗菌药物应用分析 被引量:4

Analysis on Application of Carbapenem Antibiotics in Obstetrics and Gynecology Hospital of Fudan University During 2014-2017
下载PDF
导出
摘要 目的:调查复旦大学附属妇产科医院(以下简称"我院")碳青霉烯类抗菌药物使用情况,为临床合理用药提供参考。方法:通过我院信息科调取2014—2017年碳青霉烯类抗菌药物的使用信息,并进行回顾性分析,计算和分析碳青霉烯类抗菌药物的销售金额、用药频度(defined daily dose system,DDDs)、抗菌药物使用强度(antibiotics use density,AUD)、药物利用指数(drug utilization index,DUI)及各科室使用情况;并对主要细菌的耐药情况进行分析。结果:2014—2017年,我院碳青霉烯类抗菌药物的销售金额及其占抗菌药物总销售金额的比例呈逐年升高趋势,其销售金额占抗菌药物总销售金额的比例由2014年的2.30%升至2017年的5.38%,其DDDs从495.25升至1 320.00,AUD从0.17 DDDs/(100人·d)升至0.47 DDDs/(100人·d);4年来,注射用亚胺培南西司他丁钠的DDDs排序始终居第1位,其DUI分别为0.79、0.86、0.78及0.84;妇科某病房注射用亚胺培南西司他丁钠的使用量排序居首位;主要检出革兰阴性菌大肠埃希菌和肺炎克雷伯菌对碳青霉烯抗菌药物的耐药率保持稳定。结论:2014—2017年我院碳青霉烯类抗菌药物的销售金额及其占抗菌药物总销售金额的比例、DDDs及AUD逐年升高,其在妇科某病房的使用量排序始终居首位;虽然大肠埃希菌及肺炎克雷伯菌对碳青霉烯类抗菌药物保持高度敏感,但仍需加强对该类抗菌药物临床应用的管控,减少和延缓细菌耐药。 OBJECTIVE: To investigate the application of carbapenem antibiotics in Obstetrics and Gynecology Hospital of Fudan University(hereinafter referred to as "our hospital"), so as to provide references for clinical rational application of drugs. METHODS: Retrospective analysis was conducted on application data of carbapenem antibiotics during 2014-2017 extracted from department of information in our hospital, the consumption sum, defined daily dose system(DDDs), antibiotics use density(AUD), drug utilization index(DUI) and application of various departments of carbapenem antibiotics were calculated and analyzed. And the drug resistance of main bacteria was analyzed. RESULTS: During 2014-2017, the consumption sum of carbapenem antibiotics and its proportion in the total consumption sum of antibiotics increased year by year in our hospital, and its proportion of consumption sum to the total consumption sum of antibiotics increased from 2.30% in 2014 to 5.38% in 2017, its DDDs rose from 495.25 to 1 320.00, and AUD rose from 0.17 DDDs/(100 people ·d) to 0.47 DDDs/(100 people·d). For four years, the DDDs of imipenem cilastatin sodium for injection ranked the first, with DUI of 0.79, 0.86, 0.78 and 0.84, respectively. The consumption amount of imipenemesitine sodium for injection in the gynecological ward ranked the first. The drug resistance rate of gram-negative bacteria E. coli and klebsiella pneumoniae to carbapenem antibiotics was stable. CONCLUSIONS: During 2014-2017, the consumption sum of carbapenem antibiotics and its proportion of the total consumption sum of antibiotics, DDDs and AUD increased year by year in our hospital, and its application in the gynecological ward always took the lead. Although E. coli and klebsiella pneumoniae are highly sensitive to carbapenem antibiotics, it is still necessary to strengthen the control clinical application of antibiotics, so as to reduce and delay the bacterial resistance.
作者 王先利 高晶 韩天麟 汤静 WANG Xianli;GAO Jing;HAN Tianlin;TANG Jmg(Dept.of Pharmacy,Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200011,China;Dept.of Clinical LaboratotT,Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200011,China;Dept.of hffot~nation,Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200011,China)
出处 《中国医院用药评价与分析》 2018年第10期1388-1390,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 上海市临床药学重点专科建设项目(No.AB83110002017005)
关键词 碳青霉烯类抗菌药物 用药频度 抗菌药物使用强度 药物利用指数 细菌耐药 Carbapenem antibiotics DDDs AUD DUI Bacterial resistance
  • 相关文献

参考文献12

二级参考文献73

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2孟兆珂,乔致芬,张筱,李之.合理应用抗菌药物的临床分析[J].齐鲁药事,2005,24(9):550-551. 被引量:35
  • 3Health Protection Agency. Guidance on carbapenern resistance producers[EB/OL]. [2011-01-28] http://www.hpa. org. uk/web/HPAweb & Page& HPAwebAutoListName/Page/1294740725255.
  • 4Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenernase-producing bacteria[J]. Lancet Infect Dis, 2009, 9(4): 228- 236.
  • 5Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study[J]. Lancet Infect Dis, 2010, 10(9): 597-602.
  • 6Carrer A, Poirel L, Yilmaz M, et al. Spread of OXA-48 encoding plasmid in Turkey and beyond[J]. Antimicrob Agents Chernother, 2010, 54(3): 1369-1373.
  • 7Cohen Stuart J, Leverstein-Van Hall MA. Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screen- ing and confirmation of carbapenemases in Enterobacteriaceae[J]. Int J Antimicrob Agents, 2010, 36(3) : 205-210.
  • 8Pournaras S, Poulou A, Tsakris A. Inhibitor-based methods for the detection of KPC carbapenernase-producing Enterobacteriaceae in dinical practice by using boronic acid compounds[J]. J Antimicrob Chemother, 2010, 65(7): 1319-1521.
  • 9Miriagou V, Cornaglia G, Edelstein M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues[J]. Clin Microbiol Infect, 2010, 16(2) : 112-122.
  • 10Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobac- teriaceae in acute care fadlities[J]. MMWR Morb Mortal Wkly Rep, 2009, 58(10) : 256-260.

共引文献346

同被引文献25

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部